|
| 'Chitosan (1) | 1 (2) | 1, 3, 4 - oxadiazoles (1) |
| 1,2,3,4-tetrahydro-9Hpyrido [3,4-b] indole-3-carboxylic acid (1) | 1,3,4-Oxadiazole (1) | 1,3,4-Oxadiazoles (1) |
| 1-butyl-3-methyl imidazolium bromide (1) | 1-butyl-3-methyl imidazolium chloride. (1) | 1-methyl-4-phenyl-1 (1) |
| 18 β-glycyrrhetic acid (1) | 2 (2) | 2, 5-diaza bicyclo [4.3.1] compounds (1) |
| 2,2-diphenyl-1-picrylhdrazyl (1) | 2-(N-hydroxymethyl amino)-indol-3-yl-propanoic acid (1) | 2-aminobenzothiazole (1) |
| 2-Hydroxypropyl-β-cyclodextrin (1) | 23 factorial design (1) | 25(OH)2D (1) |
| 3 (2) | 3-Methyl-2-benzothiazonium hydrazone hydrochloride (1) | 32 factorial design (1) |
| 3D QSAR (1) | 3D-QSAR (1) | 3’ UTR region (1) |
| 4 - acetamido phenoxy acetyl hydrazide (1) | 4-dihydroxy-4-methoxybenzophenone- 2-O-β-d-glucopyranoside (1) | 4-pyridinecarboxylic acid hydrazide (1) |
| 4-Thiadiazole-2-amine (1) | 5-fluoroindolin-2-one (1) | 5-Fluorouracil (1) |
| 5-HT 3 receptor antagonists (1) | 5-Piperazinedione (1) | 6 (1) |
| 6-Mercaptopurine (1) | 6-Methylmercaptopurine (1) | 6-tetrahydropyridine (MPTP) (1) |
| 7-Hydroxy warfarin. (1) | 8-iso-Prostaglandin F2α (1) | A. nilotica (1) |
| ABC analysis (4) | ABC-VED matrix (4) | Abdominal Pregnancy (1) |
| Abheshaja (1) | Absorbance ratio (1) | Absorption ratio (1) |
| ABTS (1) | Abuse (1) | Academic Stressors scale (1) |
| Accuracy. (1) | Accurate (1) | ACE (2) |
| ACE inhibitor (1) | Aceclofenac (1) | Acetazolamide (1) |
| acetic acid induced writhing test (1) | Acetyl cholinesterase estimation (1) | Acetyl isoniazid (1) |
| Acetylation rate (1) | Acetylcholinesterase (1) | Acetylcholinesterase inhibitors (1) |
| ACF (1) | Acid hydrolysis (1) | Acid violet 43 (1) |
| Acid-resistant capsules (1) | Acne (1) | Acne vulgaris (1) |
| Aconitine (1) | Acquired immune deÞ ciency syndrome (1) | Acrylamide grafted ghatti gum; Biodegradable; Diclofenac sodium; pH-sensitive hydrogel; Controlled-release. (1) |
| Actinomycetes (1) | Activator procaspase-3 (1) | active pharmaceutical ingredient (1) |
| Active site (1) | Activities of daily living (ADL) scale (1) | Acupuncture (1) |
| Acute appendicitis (1) | Acute generalized exanthematous pustulosis (1) | Acute Inflammation (1) |
| Acute inß ammation (1) | Acute poisoning (1) | Acute ST segment elevation myocardial infarction (1) |
| Acute toxicity (1) | acyclovir (2) | Adenanthera (1) |
| Adenosine A 2A antagonist (1) | Adherence (5) | Adherence. (1) |
| Adiantum venustum (1) | ADME properties. (1) | ADR (2) |
| ADR management (1) | ADR monitoring centre (AMC). (1) | ADRs (2) |
| Adsorbent (1) | adverse drug events (1) | Adverse drug reaction (9) |
| Adverse Drug Reaction (ADR) (1) | Adverse Drug Reaction and Antihypertensive medications. (1) | Adverse drug reaction. (1) |
| Adverse Drug Reactions (8) | Adverse drug reactions (ADRs) (1) | Adverse event following immunization (AEFI) (1) |
| Adverse events (1) | Adverse reaction (1) | Aedes aegypti (2) |
| Aerobic exercise (1) | Aerosil (1) | affective ; assessment ; cognitive ; learning domains ; psychomotor (1) |
| Age (2) | Ageratum conyzoides L (1) | air pollution (1) |
| Airjet (1) | Albendazole (1) | Albino mice (1) |
| Albino wistar rats (1) | Alcohol (2) | alcoholic extract (1) |
| ALDEN (1) | Aldose reductase inhibitors (1) | allantoin (1) |
| Allergic rhinitis (1) | Allergy (4) | Alloxan (1) |
| Alloxan monohydrate (1) | Alocasia indica Schott (1) | Aloe vera (1) |
| Alpha-adrenoceptor (1) | alpha-delta-bungarotoxin-4 (1) | Alpinia speciosa (1) |
| Alprazolam (1) | Alteration of drug cost (1) | Altered Mental Status (AMS) (1) |
| alternative therapy (1) | Alzheimer's disease (1) | Alzheimers disease (1) |
| Alzheimer’s disease (1) | Amaranthus spinosus Linn (1) | Amber (1) |
| Ambroxol hydrochloride (1) | Amides (1) | Amikacin Sulfate (1) |
| Amino acids (1) | amino benzylated Mannich bases (1) | amivudine (1) |
| Amlodipine (2) | Amlodipine besylate (2) | Ammonium salts (1) |
| Amoora cucullata. (1) | amoxicillin (1) | Amoxicillin sodium (1) |
| Anabolic. (1) | Analgesia (1) | analgesic (8) |
| Analgesic effect (1) | analgesic- anti-inß ammatory activity (1) | Analgesics (1) |
| Analysis in capsules (1) | Analysis of variance (1) | Anaphylactic shock (1) |
| Anaphylaxis. (1) | and TGF–β (1) | Andragogy (1) |
| Anemia (1) | Anethum graveolens (1) | Angiogenic growth factors (1) |
| antepartum (1) | anthelmintic (1) | anthelmintic property (1) |
| Anthocyanin (1) | Anthracyclines (1) | Anti aging (1) |
| Anti hyperglycemic (1) | Anti inflammatory (1) | anti-anxiety activity (1) |
| Anti-asthmatic activity (1) | Anti-Cancer Activity (1) | Anti-diabetes mellitus. (1) |
| Anti-diabetic drugs (1) | Anti-epileptic drugs utilization (1) | Anti-HIV (1) |
| anti-hypertensive agent (1) | Anti-infective (2) | Anti-infective agents (1) |
| anti-inflammation (1) | anti-inflammatory (7) | Anti-inflammatory Activities of Total Leaf Extracts of Ficus sycomorus L. (Moraceae) used in Traditional Medicine in the Treatment of Sickle Cell Disease (1) |
| anti-inflammatory activity (2) | anti-inflammatory activity', (1) | anti-inflammatory agent (1) |
| anti-inß ammatory (3) | Anti-inß ammatory activity (1) | Anti-obesity (1) |
| Anti-oxidant (2) | Anti-parkinsonism activity (1) | anti-spasmodic drug (1) |
| Anti-tumor agent (1) | antiamnesic agents (1) | Antianxiety (1) |
| antibacterial (3) | antibacterial activity (4) | Antibacterial drugs (1) |
| Antibiotic (2) | antibiotic guidelines (1) | Antibiotic Resistance (2) |
| Antibiotics. (1) | Anticancer (4) | Anticancer activity (1) |
| Anticancer drugs (1) | Anticholinergic (1) | Anticoagulant (1) |
| Anticoagulant service (1) | anticonvulsant activity (1) | anticonvulsants (1) |
| Anticovulsant (1) | Antidepressants (1) | Antidesma bunius (1) |
| Antidiabetic (2) | Antidiabetic activity (2) | Antidiabetic agents (1) |
| antiepileptic agents (1) | Antiepileptic Drugs (2) | antifungal (1) |
| antifungal activity (1) | Antigen (1) | antigen protein (1) |
| Antiglycation (1) | Antihistaminic (2) | Antihyperglycemic (1) |
| Antihypertensive (1) | Antihypertensives (1) | Antiinflamatory (1) |
| Antimalarial (2) | Antimicrobial (4) | Antimicrobial activities (1) |
| Antimicrobial activity (6) | Antimicrobial agent (1) | Antimicrobial efficacy (1) |
| Antimicrobial resistance (1) | Antimicrobial resistance; Prescribing practice; Anti-infective agents; Antibacterials; Pharmacoepidemiology. (1) | Antimicrobial Stewardship (1) |
| Antimicrobials (4) | Antimosquito (1) | Antimycotic Activity (1) |
| antinociceptive (1) | Antioxidant (19) | Antioxidant ; carotenoid ; humans ; half-life ; status ; absorption . (1) |
| Antioxidant activity (6) | antioxidant effect (1) | Antioxidant properties (1) |
| Antioxidants (6) | Antipsychotics (1) | antipyretic (2) |
| Antiretroviral drugs (1) | Antiretroviral therapy (2) | Antispasmodic (1) |
| Antithrombotic (2) | Antithyroid drugs (1) | Antitubercular (1) |
| Antitubercular drugs. (1) | antiulcer (1) | Antivenom (1) |
| Antivenom reactions (1) | Antiviral (1) | antiviral activity (1) |
| Antiviral RNA (1) | Anxiety (2) | APAP (1) |
| APC (1) | Apoptosis (2) | Application (1) |
| Application to PK profile studies (1) | applications (1) | Appropriateness (1) |
| Aqueous extract (3) | AR Caps (1) | Arabic gum (1) |
| ARDS (1) | Area above the blood glucose levels-time curve. (1) | area of wound healing (1) |
| Areca nut (1) | Arginase (2) | Arginine (1) |
| Armodafinil (1) | ART (1) | Artemia salina (1) |
| Artemia salina. (1) | Artemisia absinthium (1) | Artemisia macrocephala (1) |
| arterial hypertension (1) | Arteriovenous malformation (AVM) (1) | Arthritis (1) |
| ARV Drugs (1) | Ascorbic acid (3) | Asenapine (1) |
| asian developing nations (1) | Asiaticoside (1) | Asparagus racemosus root extract (1) |
| Aspergillus niger (2) | Aspergillus niger. (1) | Aspergillus terreus (1) |
| Aspirin (1) | Assay (2) | Asthma (4) |
| Asymptomatic neurocognitive impairment (1) | Ataxia (2) | ATC/DDD (3) |
| Atherosclerosis (1) | Atherosclerotic Vascular Disease (1) | Atorvastatin (5) |
| Atorvastatin calcium (1) | Atorvastatin. (1) | ATP synthase inhibitor (1) |
| ATP- sensitive K+channel (1) | Atractylis flava Desf (1) | Atrial fibrillation (1) |
| Atropine (1) | Attitude (6) | Attitude and practice (1) |
| Attitude. (1) | Aucubin (1) | Authors (1) |
| Authorship issues (1) | Autism spectrum disorders (1) | Auto antibody (1) |
| Auto medication (1) | Autoimmune disorders (1) | Autoimmunity (1) |
| Averrhoa bilimbi (1) | Avicel (1) | Awareness (2) |
| Ayurveda (1) | Azelaic acid (1) | Azilsartan medoxomil (1) |
| B cell epitope (1) | Bacoside A3 (1) | Bacterial isolates (1) |
| Bacteriological culture (1) | Bacteriostatic (1) | Bamboo betung (1) |
| Banana (1) | Bangladesh (2) | bark (1) |
| Barleria cristata (1) | Barriers (1) | Bauhinia racemosa (1) |
| Bauhinia variegata (2) | Bay-K-8644 (1) | Bayesian confidence propagation neural network (1) |
| BCG vaccine (1) | BCS-IV drug (1) | Beauty Salon Owner (1) |
| Beck Depression Inventory (1) | Beck Depression Inventory(BDI) (1) | Bedaquiline (1) |
| Belief (1) | Benchmarking (1) | Benzimidazole derivative (1) |
| benzimidazoles (2) | Benzodiazepines (1) | Benzothiazole analogues (1) |
| Berberis integerrima Bunge (1) | Beta-lactamic (1) | Bibliometrics (3) |
| Bioactive Metabolites (1) | Bioadhesive (1) | Bioanalytical method (1) |
| Bioanalytical method development (1) | Bioassay (1) | bioavailability (5) |
| Biodegradable (1) | Bioethics (1) | Biohazard (1) |
| Biologics (1) | Biology (1) | Biomedical (1) |
| Bioprospecting. (1) | Biopsy Proven Acute Rejection (1) | Biosafety (1) |
| Biosafety Engineering Control (1) | Biotechnology (1) | Bitter (1) |
| Black tea extract (1) | Bleaching (1) | Bleeding time (1) |
| Bleomycin (1) | Blonanserin (1) | Blood brain barrier (1) |
| Blood glucose (1) | Blood pressure (3) | Body Mass Index (1) |
| Boerhaavia Diffusa (1) | Bone (1) | Book Review (1) |
| Borg scale (1) | botulinum toxin (1) | Box-Behnken (1) |
| Brahmi vati (1) | Brain (1) | brand name drugs (1) |
| Branded medication (1) | Bratton-Marshall reagent (1) | Brazil (1) |
| Breast cancer (5) | Brewer’s yeast (1) | Brief COPE scale (1) |
| Brief medication questionnaire (1) | Brimonidine tartrate (1) | brine shrimp lethality bioassay (1) |
| Brine-shrimp lethality. (1) | Bromelain (1) | Bromeliaceae (1) |
| Bromocresol purple (1) | Bronchial Asthma (1) | Bryonia laciniosa (1) |
| Buccal (1) | Buccal Patches (1) | budget forecasting (1) |
| Bufadienolide (1) | Bullous eruption (1) | bungarotoxin (1) |
| Bungarus caeruleus (1) | Bungur (1) | Buni-berry extract (1) |
| Buoyant microspheres (1) | Burden Of Disease (1) | Business method (1) |
| Business model (1) | Butea monosperma (1) | C934 (1) |
| Ca2+ channels (1) | Cadmium chloride (1) | Caesalpinia decapetala (1) |
| Caesalpinia pulcherrima (1) | Caesalpinia pulcherrima (L.) Sw. stem bark (1) | Calcineurin inhibitor (1) |
| Calcium (1) | Calcium channel blocking (1) | calcium channel blocking activity (1) |
| Calcium oxalate (1) | Calcium silicate (1) | Calendula officinalis (1) |
| calendula oil (1) | Camelia sinensis extract (1) | Camellia sinensis (1) |
| Camptothecin (1) | Cancer (4) | Cancer Chemotherapy (2) |
| Cancer treatment (1) | Candida (1) | Candida albicans (3) |
| Candida albicans. (1) | Capacity (1) | Capsule (1) |
| capsules (1) | carbamazepin (1) | Carbamazepine (2) |
| carbohydrazide (1) | Carbomyl Linkage (1) | carbon tetrachloride (1) |
| carbonyl compounds (1) | Carbopol 940 (1) | Carcinoma. (1) |
| cardiac arrhythmias (1) | Cardiac remodeling (1) | Cardiology (1) |
| Cardioprotection (1) | Cardioprotective (1) | Cardiotoxicity (2) |
| Cardiovascular disease (1) | Carnauba wax (1) | carrageenan (2) |
| Caryocar coriaceum (1) | Case report (1) | Casein (1) |
| Casein Phosphopeptide-amorphous calcium Phosphate (1) | Catalase (1) | catalepsy (2) |
| Cation-pi (1) | CationicGuargum (1) | Causality assessment (2) |
| Causality scales (1) | CCKNOW - Crohn’s and Colitis Knowledge assessment questionnaire (1) | Cefixime (1) |
| Cefotaxime (1) | ceftriaxone and co-amoxiclav (1) | Cefuroxime Axetil (1) |
| cell viability Glycyrrhiza glabra (1) | Cellulase (1) | Cellulite (1) |
| Cellulitis (1) | Cellulose (2) | Cemented (1) |
| Cementless (1) | CEN (1) | Centella asiatica (3) |
| Central composite design (4) | Central post-stroke pain (1) | Cephalexin (2) |
| Cerebrovascular Accident (1) | Cervical dentine hypersensitivity (1) | CFFF (1) |
| chalcone (1) | chalcones (1) | Characterization (4) |
| Chemical stability (1) | Chemomechanical removal (1) | Chemometrics (2) |
| Chemotherapy (5) | Chewing gum (1) | Child Care (1) |
| Children (2) | Children Dentistry (1) | Chitin (1) |
| Chitosan (6) | Chitosan Acetate. (1) | chitosan microspheres (1) |
| Chitosan nanoparticle (1) | Chitosan-g-HPβCD (1) | Chlamydomonas reinhardtii (1) |
| Chloramphenicol (1) | Chlorhexidine (2) | Chlorohexidine (1) |
| cholesterol (1) | Cholesterol HDL (1) | Cholinesterase inhibitors (1) |
| Chromotropic acid reagent (1) | Chronic Obstructive Pulmonary Disease (COPD) and Elderly Patient. (1) | Chrysophyllum cainito L. leaves (1) |
| Cicer arietinum (1) | Cigarette smoke (1) | Cilostazol (1) |
| Cinnamaldehyde (1) | Cinnamic acid derivatives (1) | Cinnamomum cassia (1) |
| Ciprofloxacin (1) | Citronella (1) | Citrus hystrix (1) |
| Citrus limon (2) | CKD (1) | CKMB. (1) |
| Claims (1) | Clarithromycin (1) | Classification (1) |
| Clastogenicity (1) | Cleistanthin A (2) | cleistanthin B (2) |
| Cleistanthus Collinus (1) | Clinical attachment level (1) | Clinical efficacy (1) |
| Clinical equivalence (1) | Clinical manifestation (1) | Clinical Pharmacist (1) |
| Clinical pharmacist care (1) | Clinical pharmacology (1) | Clinical research (1) |
| Clinical trial (1) | Clinical trials (1) | Clinicians (1) |
| clonidine (2) | Clopidogrel (1) | Closed melt (1) |
| Clove (1) | cloxacillin (1) | Cluster analysis (1) |
| CME (1) | Co-crystal (1) | Co-Morbidity (1) |
| Co-morbidity. Correspondence (1) | co-precipitation method (1) | Co-surfactant (1) |
| Cochlopermum tinctorium (1) | coding system (1) | Cognition (2) |
| Cogrinding (1) | Colloidal carriers (1) | Colloidal silicone dioxide (1) |
| Colon targeted delivery (1) | Colon targeted drug delivery. (1) | Colonic delivery (1) |
| colorimetric assay (1) | Combination tablet (1) | Combination Therapy (1) |
| Combinatorial effect (1) | Comet assay (1) | common cold (1) |
| common cold and cough (1) | Common warts (1) | Community Pharmacies (1) |
| Community pharmacist (1) | Community pharmacy (1) | Comorbidity (1) |
| comparative molecular similarity indices (1) | comparative molecular Þ eld analysis (1) | compensation (1) |
| Complementary and alternative medicine (2) | complementary and alternative medicines (1) | Complementary and alternative therapy (1) |
| complete epithelization (1) | Compliance (1) | compound 48/80 (2) |
| compritol 888 ATO (1) | Computer (1) | Computer literacy (1) |
| computer-aided instructions (1) | Computer-aided learning (1) | Computerized screening systems (1) |
| CoMSIA (1) | Constipation (1) | Consumer (1) |
| Consumer perception (1) | Content validation (1) | content validity (1) |
| continuing education (1) | Contract research (1) | Contract research organizations (1) |
| Controlled release (4) | convolution (1) | convulsions (1) |
| cooperative practice (1) | COPD (2) | Coprocessed excipient (1) |
| Cordia obliqua (1) | Corneal opacities (1) | Coronally advanced flap (1) |
| Correlation (2) | Corticosteroid (2) | Corticosteroids (1) |
| Cosmetic (2) | Cost avoidance (1) | Cost of illness (2) |
| Cost saving (1) | Cost-effectiveness analysis (1) | Cost. (1) |
| Costing Analysis. (1) | Cotton oil (1) | cotton pellet (1) |
| Cough (1) | Cough medicine (1) | cough. (1) |
| Counterfeit Pharmaceutical Products (1) | Cramer’s Matrix method (1) | CRC (1) |
| Cream (1) | creatinine (1) | Critical Care Unit (CCU) (1) |
| Critical Thinking (1) | cromolyn sodium (1) | Croscarmellose sodium (CCS) (1) |
| Crospovidone (1) | Crospovidone (CP) (1) | Cross carmellose sodium (1) |
| cross-linking agents (1) | Crossandra (1) | Croton zehntneri (2) |
| Crystallinity (2) | CTCAE (1) | CTEPH (1) |
| Cucumis metuliferus (1) | Cucumis sativus (1) | CUMIN. (1) |
| Cuminosides (1) | Curcuma longa (1) | Curcumin (2) |
| current indian scenario of drug interactions (1) | curriculum development (1) | Cutaneous Adverse Drug Reactions (CADRs) (1) |
| CXCR4 (1) | Cyclooxygenase (1) | cyclophosphamide (1) |
| Cymbopogon citratus (1) | Cynodon dactylon (2) | CYP genes ; South Indian population ; polymorphisms (1) |
| Cyst (1) | Cytochrome P 2C9 (1) | Cytotoxic (1) |
| Cytotoxic activity. (1) | Cytotoxic agents (1) | Cytotoxicity (2) |
| CZE (1) | D&C (1) | D-optimal design (1) |
| Daily Defined Dose (1) | Dapsone (1) | Data mining algorithms (1) |
| DDX3 (1) | Death Receptors (1) | Decision making (1) |
| Deep vein thrombosis (1) | deferasirox (1) | deferiprone (1) |
| Deficiency (1) | Degradation (1) | Degradation studies (1) |
| Dehydrozingerone (1) | Delignification (1) | Delirium (2) |
| democratic government (1) | Dengue high fever (1) | Dental caries (3) |
| Dental Caries. (1) | dental management (1) | Dental prosthesis. (1) |
| Dental Students (1) | dentistry. (1) | Deodorants (1) |
| Dependence (1) | Depigmentant (1) | Depok Primary Health Care (1) |
| Deprescribing (1) | Depression (3) | Dermatology life Quality Index (1) |
| Design of experiments. (1) | desirability function (1) | Desirability index. (1) |
| Desmodium gangeticum (1) | Detorsion (1) | Deuterium (1) |
| device safety (1) | dexamethasone (2) | Dexibuprofen (1) |
| Dextrin (1) | Diabetes (4) | diabetes and diabetic vascular complications (1) |
| Diabetes mellitus (11) | diabetes mellitus, (1) | Diabetes Type-II (1) |
| Diabetes, glucose (1) | diabetic dyslipidemia (1) | Diabetic nephropathy (1) |
| Diabetic retinopathy (1) | Diabetic Wound (1) | Diacerein (1) |
| DiaKure (1) | diclofenac (1) | Diclofenac SLN (1) |
| Diclofenac sodium (1) | Dicots (1) | Dicyclomine (1) |
| differential scanning calorimetry (1) | diffuse transmittance (1) | Dillenia indica (2) |
| Dilleniaceae (1) | Diltiazem Efficacy (1) | Diltiazem hydrochloride (2) |
| Dimethylpyrimidin-derivatives (1) | Dip coating (1) | Diplotropis ferruginea (1) |
| direct compression (3) | Direct to consumer advertising (1) | Discharge against medical advice (DAMA) (1) |
| discharge orders (1) | DISCLE (1) | Discrepancies (1) |
| Discriminant analysis (1) | Disease (1) | disintegration (1) |
| disintegration time (1) | Disproportionality Analysis (1) | Dissolution (4) |
| dissolution enhancement (1) | Dissolution rate (1) | Diuretic (1) |
| Diuretic activity (2) | DMAIC (1) | DMH (1) |
| DNA damage (1) | DNA fragmentation (1) | docking (3) |
| docking. (1) | Doctor (1) | Documentation and records (1) |
| Donepezil hydrochloride (1) | Dopamine (1) | Dosage formulation (1) |
| Dosage regimen (1) | Dose-dependent (1) | DOTS plus (1) |
| Doxorubicin (2) | Doxorubicin; FRAP assay (1) | Doxycycline (1) |
| DPPH Assay (1) | DPPH scavenging (1) | DRcaps (1) |
| DREEM. (1) | Dried blood spot. (1) | Dried blood spot; pharmacokinetic; validation; hydrochlorothiazide (1) |
| droplet size (1) | Drug (2) | Drug delivery denture (1) |
| Drug detailing (1) | drug disposal (1) | Drug Hypersensitivity (1) |
| Drug induced nephrotoxicity (1) | Drug Information and Literature Evaluation (1) | drug interaction (2) |
| Drug interaction (DI) (1) | drug interaction management (1) | drug interactions (2) |
| Drug prescriptions (1) | Drug product (1) | Drug Related Problems (4) |
| Drug related side effects (1) | drug release (1) | Drug Resistance (1) |
| Drug risk ratio (1) | Drug safety (2) | Drug Safety. (1) |
| Drug therapy (1) | Drug utilization (2) | drug utilization study (1) |
| Drug utilization. (1) | drug-drug interactions (4) | Drug-SLS tablets. (1) |
| Drugedrug interaction (1) | Drugs (2) | drug–drug gliclazide (1) |
| Drug–drug interaction (1) | Dry extract cinnamon (1) | DSPC (1) |
| Dual Therapy (1) | dual-target-directed drugs (1) | Dunaliella salina (1) |
| Dynamic (1) | Dyslipidemias (1) | Dysphagia (1) |
| e-prescribing (1) | E. coli (1) | E.crispa (1) |
| Early-Related Complications (1) | EC50 values (1) | Economic (1) |
| Economic burden (1) | Edaravone (1) | Eddy’s hot plate method. (1) |
| edema (1) | Editorial (24) | Education (2) |
| Educational excellence (1) | efavirenz (2) | Efficacy. (1) |
| EGCG (1) | Egfr (1) | egg albumin microspheres (1) |
| Elderly (1) | Elderly Patients (1) | Electrochemical (1) |
| electrolyte release (1) | electrolytes (1) | Electron beam radiation (1) |
| Electronic prescribing (1) | Electronic prescription (1) | Electroporation (1) |
| Elevated plus maze (1) | elevated plus maze model (1) | Elisa (1) |
| Emblica offi cinalis (1) | Emergency contraception (1) | Emodin (1) |
| Emotional (1) | Emulgel (1) | Emulsification and Solvent Evaporation (1) |
| emulsion solvent diffusion method (1) | emulsion solvent diffusion-evaporation technique (1) | Encholirium spectabile (1) |
| Endocrine disruptor (1) | Endophytes (1) | Endothelial cells (1) |
| endothelial Nitric Oxide Synthase (1) | Endothelial progenitor cells (1) | Endothelium (1) |
| Endothelium. (1) | Enicostemma littorale (1) | Entire plant (1) |
| Entrapment afficiency (1) | entrapment efficiency (2) | Envenoming (1) |
| Environmental Factors (1) | Enzymatic hydrolysis (1) | eosinophil (1) |
| Epigallocatechin Gallate (2) | Epigallocatechin gallate (EGCG) (1) | Epigenetics (1) |
| epilepsy (4) | erbal drugs (1) | erice declaration (1) |
| Erythema (1) | Erythrina indica (1) | Erythrina variegata (1) |
| erythropoietin (1) | Escherichia coli (1) | Escitalopram oxalate (1) |
| esomeprazole (1) | Essential hypertension (2) | Essential medicine (1) |
| essential medicines (1) | essential oil (4) | essential oil composition (1) |
| Essential principles (1) | Estimated Glomerular Filtration Rate (1) | Estrogen receptor alpha (1) |
| Ethanol (1) | Ethanol extract (1) | ethanolic extracts (1) |
| Ethiopia (2) | ethnicity (2) | Ethnomedicine (1) |
| Ethosomes (1) | Ethyl - 4- acetamido phenoxy acetate (1) | Ethyl acetate (1) |
| Ethyl acetate fraction (1) | ethyl cellulose (2) | ethylcellulose (3) |
| ethylene glycol (2) | Eucalyptus (1) | Eucalyptus hybrid (1) |
| Eucalyptus oil (2) | eudragit (1) | Eudragit RL 100 (1) |
| eudragit S100 (2) | Eudragit-L100 (1) | Eudragit® S100 (1) |
| Eugenol (1) | Euphorbia hirta leaves (1) | Eurycoma Longifolia Jack (1) |
| ex-vivo performance (1) | Ex-vivo permeation (1) | Ex-vivo study (1) |
| Excision wound model (1) | experiences (1) | Experimental ischemic stroke (1) |
| Exports (1) | Expression profile (1) | Extract (1) |
| Extrapyramidal side-effects (1) | extrinsic stains (1) | extrusion (1) |
| Eye lens (1) | Ezetimibe (2) | Fabaceae (2) |
| factorial design (5) | Factors associated with medication non-adherence (1) | Falcipain-2 (1) |
| Family Planning Services (1) | Family satisfaction (1) | family therapy (1) |
| famotidine (2) | fast disintegrating tablet (1) | Fast Disintegrating Tablets. (1) |
| Fast dissolving films (1) | Fast dissolving tablets (1) | Fasting serum insulin level (1) |
| Fat (1) | Fatty acid profile (1) | FC reagent (1) |
| FDA AERS Database (1) | FDA Approval (1) | Fenugreek (1) |
| Ferritin (1) | Ferrous sulfate (1) | Fialuridine', (1) |
| Ficus bengalensis (1) | Ficus bengalensis (Moraceae) (1) | Ficus racemosa (1) |
| film (1) | film hydration (1) | First permanent molars (1) |
| Fixed drug eruption (1) | Flavonoid (3) | Flavonoid Compounds (1) |
| Flavonoid fraction (1) | flavonoids (2) | Flavoxate HCl (1) |
| FlK-1 (1) | Floating beads (1) | floating controlled drug-delivery system (1) |
| Floating drug delivery system (1) | floating lag time (1) | fluoroquinoes (1) |
| Fluoxetine (1) | Flupritine maleate (1) | flurbiprofen (1) |
| Flux (1) | folkloric use (1) | Food drug and cosmetic act (1) |
| Forced degradation (3) | Forced degradation studies (1) | forced swim test (1) |
| Formulary (1) | Formulary. (1) | Formulation (2) |
| Formulation and development (1) | Fourier transform infra red spectroscopic (1) | FPG (1) |
| FPGEE (1) | Fraction (1) | Franz Diffusion Cell (3) |
| free radical scavenger (1) | Free radicals. (1) | Freeze-drying (1) |
| Freund’s complete adjuvant (1) | Fructo-Oligosaccharide (FOS) (1) | Frusemide (1) |
| Frusemide-induced complications (1) | FTIR (4) | Fumes (1) |
| furosemide (1) | Galacto-Oligosaccharide (GOS) (1) | Galic Acid (1) |
| gallic acid (2) | Gamma irradiation (1) | Gangrenous (1) |
| Ganoderma lucidum (1) | Gap Junctions; Hypersynchronization; Pentylenetetrazole; Maximal Electroshock (1) | Garcinia daedalanthera extract (1) |
| Garcinia imberti bourd (1) | Garcinia indica (1) | Garcinia latissima (1) |
| gaseous contact (1) | gastric treatment (1) | Gastric ulcer (1) |
| Gastro-retentive drug delivery system (1) | gastroprotection (2) | gastroretentive (1) |
| gastroretentive drug delivery system (1) | Gatot Soebroto hospital. (1) | GC-MS (1) |
| GC-MS analysis (2) | GC-MS. (1) | Gelatin (1) |
| Gelling Capacity. (1) | Gels (1) | gemfibrozil (1) |
| Gender (1) | Gender and HIV. (1) | Gene expression (1) |
| Gene expressions (1) | Gene silencing (1) | General medicine (1) |
| Generic (2) | generic drugs (1) | Generic medicines (2) |
| Generic name. (1) | Generic substitution (1) | Generics (1) |
| Genetic polymorphisms (1) | genetic Signature (1) | Genotype frequency (1) |
| Gentamicin (4) | gentamicin sulfate (2) | Geriatrics (3) |
| GFAP (1) | Gibb’s reagent (1) | Ginger (1) |
| Gingival hyperplasia (1) | Gingival hypertrophy (1) | gingival pocket (1) |
| Gingival recession (1) | Gingival thickness (1) | Gladiolus segetum (1) |
| glibenclamide (4) | gliclazide (2) | Glimepiride (2) |
| glimepride (1) | Glipizide (3) | glitazars (1) |
| Global education (1) | Glomerulonephritis (1) | Glucagon (1) |
| Glucocorticoids (1) | Glucose (1) | glucose tolerance test (1) |
| glutathione (1) | Glycerine (1) | Glycine max (1) |
| Glycosylated hemoglobin (HbA1c) (1) | Glycosylated hemoglobin A1c (1) | Gnetum gnemon (2) |
| Goal orientation (1) | Goldenhar syndrome (1) | good manufacturing practices (1) |
| Gotu kola leaves extract (1) | GPx (1) | Graft Survival (1) |
| Grafting (1) | Gram negative (1) | Gram positive (1) |
| Grape seed extract (1) | Grape seed oil (1) | Grapes seed extract (1) |
| Gravimetry (1) | Grazing angle X-ray diffraction (1) | Green tea (1) |
| Green Tea Leaves Extract (2) | Griseofulvin (1) | GSH (2) |
| guanyl cyclase stimulator (1) | Guest Editorial (1) | Guidelines (1) |
| Gulf cooperation council (1) | Gum and fat fractions (1) | Gum arab (1) |
| Gymnema Sylvestre (2) | GYTS (1) | H+ (1) |
| H-460 (1) | H2 Receptor Antagonist (1) | H2O2 (1) |
| HAART (1) | Haematological (1) | Haemolytic ratio. (1) |
| Hair dye. (1) | Hair Growth Activity (1) | Hair Tonic (1) |
| Hajj (1) | haloperidol (1) | Hand and Foot Syndrome (1) |
| hardness (1) | harmacotherapy-based problems (1) | Harmonization (2) |
| Hazardous drugs (1) | HbA1C (2) | HBV (1) |
| HCT: Hydrocholrothiazide. (1) | HDAC4 (1) | HDAC7 (1) |
| head twitch (1) | Health benefits (1) | Health care profession (1) |
| health care professionals (1) | health care students (1) | Health care. (1) |
| Health Hazard (1) | Health informatics (1) | Health Information Technology (1) |
| Health problems (1) | Health Services Accessibility (1) | Healthcare (4) |
| healthcare communication (1) | Healthcare Delivery (1) | healthcare expenditure (1) |
| Healthcare Professionals (1) | healthcare providers (1) | Healthy volunteers (1) |
| heart failure (2) | Hematological parameters (1) | hematological toxicity (1) |
| Hematology (2) | Hematoma (1) | hepatic impairment (1) |
| Hepatitis (1) | Hepatitis B (1) | Hepatitis B virus core protein (1) |
| Hepatocellular (1) | Hepatocurative (1) | hepatoprotective (2) |
| hepatoprotective activity (3) | Hepatotoxicity (1) | HER1 (1) |
| HER2 (1) | HER3 (1) | HER4 (1) |
| Herbal active ingredients (1) | Herbal drugs (1) | Herbal medications (1) |
| Herbal medicine (2) | herbal medicines (1) | Herbal therapy (1) |
| Herbaldb (1) | HET-CAM (1) | Heterocyclic compound (1) |
| Heterotopic Pregnancy (1) | Hex (1) | Hexane (1) |
| Hibiscus cannabinus Linn. (1) | Hibiscus rosa. (1) | High fat diet (2) |
| High Fat Diet Model (1) | High impact resin (1) | high performance liquid chromatography (1) |
| high performance thin layer chromatography (1) | High-density lipoprotein cholesterol (1) | High-fat diet (1) |
| high-performance liquid chromatography (2) | High-throughput screening (1) | Higher education (1) |
| highly active antiretroviral therapy (1) | Highly Cited Papers (1) | Himatanthus drasticus (1) |
| Hip Arthroplasty (1) | Hirsutism (2) | Histocompatibility. (1) |
| Histological studies. (1) | Histopathology (2) | HIV (1) |
| HIV associated dementia. (1) | HIV-1 RT (1) | HIV-associated neurocognitive disorder (1) |
| HIV/AIDS Patients (1) | HL-60 and K-562 (1) | HLA (1) |
| HMG-CoA Reductase (1) | homology modeling (1) | Honey (1) |
| Honeycomb (1) | Hordeum vulgare (1) | Hordeum vulgare hull (1) |
| Hospital pharmacy (2) | hospitalized children (1) | hospitalized patients (1) |
| Hospitals (1) | host (1) | hot plate (1) |
| HP-ß Cyclodextrin complexes (1) | HPLC (8) | HPLC (High Performance Liquid Chromatography) Ornidazole (1) |
| HPLC method validation (1) | HPLC. (1) | HPMC (1) |
| HPMC capsules (1) | HPMC K100M (1) | HPMC K4M (1) |
| HPTLC (5) | HRQoL (2) | HSV-1 (1) |
| Human breast cancer cells (1) | Human breast cancer MCF -7 cells (1) | human immunodeficiency virus (3) |
| human immunodeÞ ciency virus (1) | Human Papillomavirus (1) | Human plasma (2) |
| human plasma level (1) | Human plasma; Liquid chromatography–tandem mass spectrometry (LC–MS/MS); Method validation; Pharmacokinetics (1) | Humanitarian device exemption. (1) |
| Hydnocarpus Pentandra (1) | Hydralazine hydrochloride (1) | Hydroalcoholic (1) |
| hydrochlorothiazide (1) | Hydrochlorthiazide (1) | hydrogel (2) |
| Hydrogels (1) | hydrogen sulfide (1) | hydrogenated castor oil (1) |
| Hydrophilic drugs (1) | Hydrophillic sealants (1) | Hydrophobic sealants (1) |
| hydroxy propyl methyl cellulose (1) | Hydroxyl radical (1) | hydroxypropyl cellulose (1) |
| hydroxypropyl methyl cellulose (2) | Hydroxypropyl methylcellulose (1) | Hydroxypropyl methylcellulose E15 (1) |
| Hydroxypropyl-β- cyclodextrin (1) | Hydroxypropylmethyl cellulose (1) | Hydroxypropylmethylcellulose (1) |
| Hyperactive orofacial musculature (1) | Hypercholesterolemia (1) | Hypercholestremia (1) |
| Hyperglycemia (1) | Hyperglycemic (3) | Hyperglycemic mice (1) |
| Hyperhomocystienemia (1) | Hyperlipoprotienemia(a) (1) | hyperoxaluria (1) |
| Hypersensitivity (1) | hypertension (5) | Hypertension( HTN) (1) |
| Hypertensive’s (1) | Hyperthyroidism (1) | hypertriglyceridemia (2) |
| Hypertrophy (1) | Hyperzincuria (1) | Hyphenated system (1) |
| hypoglycemic (1) | Hypoglycemic activity (1) | hypolipidemic (1) |
| Hypothyroidism (1) | Hypozincaemia (1) | IBD - Inflammatory Bowel Disease (1) |
| IC50 (2) | ICH (2) | ICH guidelines (2) |
| ICP22 (US1) gene (1) | IL-17 (1) | IL-6 (2) |
| IL-MAE (2) | Illiterate (1) | Iloperidone (1) |
| image analysis (1) | imidazole (1) | Immune response (1) |
| immunocytochemistry (1) | Immunoinformatics (1) | Immunological response (1) |
| Immunomodulatory effect (1) | In silico (2) | in situ gelation (1) |
| in vitro (4) | In vitro kinetics (1) | In vitro penetration lotion (1) |
| In vitro penetration test (1) | In vitro Penetration Test. (1) | In vitro release (1) |
| In vitro–In vivo (1) | in vivo (1) | In vivo kinetics (1) |
| In-patien (1) | in-vitro dissolution study (1) | In-vitro skin permeation (1) |
| inclusion complexes (2) | indexed cost (1) | India (7) |
| India. (1) | Indian context (1) | Indian Traditional medicine (1) |
| Indion 234 (2) | Indion resin (1) | indomethacin (2) |
| Indonesia (1) | Indonesian Herbal Database. (1) | Indonesian National Health Insurance (1) |
| Industry (1) | Inequality (1) | infarct size (1) |
| infective endocarditis (1) | infertility (1) | inflammation (3) |
| inflammatory bowel disease (2) | Information need (1) | Information system (1) |
| Information Technology Officers (1) | Information tool (1) | Inhibitor MDM2 (1) |
| innovation ecosystems (1) | inorganic salts. (1) | INR (1) |
| inß ammation (2) | inß ammatory bowel diseases (1) | Insilico anticancer screening (1) |
| insulin (5) | Insulin receptor (1) | Insulin regimen (1) |
| insulin resistance (1) | Insulin resistance. (1) | insulin use in primary care (1) |
| Insulinophobia (1) | Integrase inhibitor (1) | Integrated Courses (1) |
| integrated economic analysis (1) | Intellectual Property l (1) | Intellectual property rights (1) |
| intelligent tutoring (1) | Intensive care unit (1) | Intensive Care Unit (ICU) (1) |
| Intensive Monitoring (1) | interaction (2) | interferon (1) |
| interleukins (1) | International Collaboration (1) | International HIV dementia scale (IHDS) (1) |
| international organization (1) | international organizations (1) | international trade (1) |
| Internet (1) | interpretation (1) | Interventional tool (1) |
| Intracanal medicament (1) | intraocular presuure (1) | Intrauterine Pregnancy (1) |
| inventory index (1) | inventory management (3) | investigators (1) |
| Invited Article (2) | ion pair complex (1) | Ionic gelation (1) |
| Ionic liquid (3) | Ionic liquid- based microwave-assisted extraction (1) | ionic liquid-based microwave-assisted extraction (1) |
| ionotropic gelation (1) | iontophoresis (2) | Iraq (1) |
| Iridoid glycoside (1) | iron chelation therapy (1) | Irvingia gabonensis (1) |
| isatin (3) | ischemia (1) | ischemia-reperfusion injury (1) |
| Ischemic (1) | ischemic heart disease (1) | ISO (1) |
| isoniazid (2) | isonicotinohydrazide (1) | Isoprinosine (1) |
| Isopropyl myristate (1) | isoproterenol (1) | isoxazoline (1) |
| itopride HCl (1) | JNC 8 Guidelines. (1) | Journal (1) |
| Jurkat (1) | K+-ATPase β subunit (1) | K+ATP channel (1) |
| K-CAPS (1) | K562 (1) | Kaffir lime (1) |
| Kajjali (1) | Kalanchoe Pinnata (1) | KAP (1) |
| KAP study (1) | Kappa. (1) | Karachi (2) |
| Kathakakhadiradi kashyam (1) | Kati chakrasana (1) | Kernel powder (1) |
| Ketoprofen (1) | Ketorolac (1) | Ketorolac salt (1) |
| Key words: 5-FU (1) | Key words: Esomeprazole (1) | kidney (2) |
| kinetic drug release (1) | Kinetic Modelling (1) | KMnO4 (1) |
| kneading method (1) | kneading technique (1) | knowledge (9) |
| Kumar’s score (1) | L-arginine (1) | L-Thyroxine (1) |
| L. acidophilus (1) | labeling (1) | Laboratory findings. (1) |
| Lactobacilli (2) | Lactobacillus (1) | Lag period (1) |
| Lagenaria siceraria (1) | Lantana camara (1) | Lantana montevidensis (1) |
| Larvacidal (1) | LC/MS/MS (1) | LC50 (1) |
| LCMS/MS (1) | LC–MS/MS (1) | LDL-C (1) |
| Leaf (1) | Learning process (1) | leaves (4) |
| Leftover medicines, (1) | Leg Length (1) | Leptin (1) |
| Letter to Editor (4) | Letter to the Editor (3) | Letters to the Editor (6) |
| Leucaena leucocephala (1) | Leucas lavandulaefolia (1) | Levocetirizine (1) |
| Lichen planus (1) | Licofelone (1) | Ligand-based drug design (1) |
| Lightening (1) | Limb Length (1) | Limbs (1) |
| lime fruit (1) | Linoleic acid (1) | lipid matrix (1) |
| lipid metabolism (2) | lipid microspheres (1) | Lipid nanocrystals (1) |
| Lipid peroxidation (3) | lipid peroxides (1) | lipid profile (1) |
| Lipid profile membrane bound enzymes (1) | lipids (1) | lipoic acid (1) |
| liposome (1) | Lippia (1) | lithium toxicity (1) |
| Live-well™ (1) | liver function (2) | Liver necrosis (1) |
| Liver tonic (1) | Liver Transplantation (1) | Local drug delivery (1) |
| locomotor activity (1) | Low-density lipoprotein cholesterol (1) | Lozenges (1) |
| Luffa echinata (1) | Luminesce (1) | Lung (1) |
| Lung cancer (3) | Lupenoic acid (1) | Lupus (1) |
| Lycatab C (1) | Lympadenopathy (1) | lymphadenitis (1) |
| Lysozyme (1) | M. tuberculosis H37Rv (1) | Maceration (1) |
| Macromicroscopy study (1) | Macrophage cell line (1) | Mahkoside A (1) |
| Major Contributed Organizations (1) | Malaysia (4) | Malaysia. (1) |
| Malaysian. (1) | malondialdehyde (2) | Maltodextrin (2) |
| Mammary carcinoma (1) | Mandibular hypoplasia (1) | Mangiferin (1) |
| Mangosteen Peels (1) | manidipine dihydrochloride (1) | Mannich base (1) |
| Mannich Bases (1) | Marine fungi compounds (1) | Mast cell (1) |
| Maternal Care. (1) | matrix (1) | Matrix Tablet (1) |
| matrix tablets (3) | MCF-7 (1) | MDA (2) |
| MDR-TB (2) | mean age (1) | mechanisms (1) |
| Meclizine HCl (1) | Medical (1) | medical costs (1) |
| Medical device (1) | Medical device recalls (1) | medical errors (1) |
| Medical informatics (1) | Medical Inpatients (1) | Medical practitioner (1) |
| Medical Representative (1) | Medical sales representative (1) | Medical students (2) |
| medication adherence (4) | medication adherence behaviour (1) | medication error (2) |
| Medication errors (1) | Medication non-adherence (1) | Medication reconciliation (1) |
| Medication regimen complexity (1) | medication safety (1) | medication-/drug-related problem (MRP/DRP) (1) |
| Medicinal plants (2) | Medicine (2) | medicine-use practices (1) |
| Melanesia (1) | Melastoma malabathricum (1) | Melinjo (2) |
| Meloxicam (1) | Memory (1) | Memory and learning. (1) |
| Men (1) | Menstrual cycle (1) | Mental health (1) |
| Mental health services. (1) | Mentha arvensis (1) | mesalamine (1) |
| Metabolic ratio (1) | Metabolic syndrome (1) | Metabolism (1) |
| Metabolite profiling (1) | Metabomics (1) | metagenomic (1) |
| metformin (7) | metformin hydrochloride (1) | Methanol (1) |
| methanolic extract (1) | methocel (1) | method development (2) |
| method validation (3) | Methotrexate (1) | methyl orange (1) |
| methyl-b cyclodextrin (1) | metoprolol tartarate (1) | MetS (1) |
| Mevalonate (1) | Micro emulsion (2) | Micro particles. (1) |
| Micro-emulsion (1) | microbial contamination (1) | Microbiological (1) |
| Microbroth dilution (1) | Microcapsules (1) | microcrystalline cellulose (5) |
| microdilution (1) | Microdosing (1) | Microencapsules (1) |
| microneedles (1) | Micronucleus assay (1) | microparticles (1) |
| microsphere (1) | Microsphere Phytosome (1) | microspheres (6) |
| microtriches (1) | Microwave assisted extraction (1) | Microwave-Assisted Extraction (2) |
| miglitol (1) | Migraine (2) | migraine management, (1) |
| Mild neurocognitive disorder (1) | Milk (1) | Milnacipran (1) |
| Mimosa pudica (1) | Mineral trioxide aggregate (1) | minimal inhibitory dose (1) |
| Minimum Inhibitory Concentration (MIC) (1) | mismatches (1) | mitochondria (1) |
| Mix mode (1) | MMAS-8 - Modified Morisky Adherence Scale-8 (1) | Modeling (1) |
| modern medicine (1) | modified melt dispersion technique (1) | Modified Starches (1) |
| Mol inspiration (1) | Molecular characterization (1) | Molecular docking (10) |
| molecular docking and anti cancer activity. (1) | Molecular Docking. (1) | Molecular Dynamic (1) |
| Molecular dynamics (3) | Molecular Dynamics Simulations (1) | Molecular mimicry (1) |
| monoamine oxidase B (1) | Monocots (1) | montelukast (2) |
| montelukast sodium (1) | Montelukast, (1) | moraceae (1) |
| Morbidity (1) | Morin and validation (1) | Moringa oleifera (2) |
| Moringa oleifera. (1) | Morisky medication adherence questionnaire (1) | Mortality (3) |
| Morus alba (1) | Mosquito repellent (1) | Mouth Dissolving Tablets (1) |
| mouth-dissolving film, (1) | MPTP (1) | MTT Assay (2) |
| MTT method (1) | MUC2 (1) | MUC6 (1) |
| Mucoadhesive (1) | Mucoadhesive agent (1) | mucoadhesive formulation (1) |
| Mucoadhesive Oral In situ gel (1) | mucoadhesives (1) | mucodhesive (1) |
| Mulberry (1) | multi granules (1) | multidrug resistant pathogens (1) |
| Multikinase Inhibitor (1) | multiparticulates (1) | multiparticulates dosage form (1) |
| Multiple myeloma (1) | multiple regression (1) | multiple regression analysis (1) |
| Multitargeted drug (1) | Murraya koenigii L.Sprengel S.mutans (1) | Mycobacterium tuberculosis. (1) |
| Mycophenolate mofetil (1) | Mycophenolic acid (1) | myocardial infarction (1) |
| Myomectomy. (1) | Myrica esculenta (1) | Myristicin (1) |
| N-aminoimidazoles (1) | N-napthyl ethylene diamine dihydrochloride (1) | Na+/K+-Atpase (1) |
| NABP (1) | NACO. (1) | Nadi shuddhi pranayama (1) |
| Naftopidil (1) | nano size (1) | Nanoemulsion (1) |
| Nanoformulation (2) | nanoformulations (1) | Nanonization. (1) |
| Nanopacticle (1) | Nanoparticle (1) | Nanoparticles (9) |
| Nanosuspension (1) | Nanosuspension tablets (1) | Nanosuspensions (1) |
| Naphthoquinone derivative (1) | NAPLEX (1) | naproxen (1) |
| Naranjo (1) | Naranjo algorithm (2) | Naranjo algorithm. (1) |
| Naranjo’s ADR probability scale (1) | Narikel Lavan (1) | Narrow therapeutic index drugs (1) |
| Nasal gel (1) | Nateglinide (1) | National Fomulary (1) |
| National Formulary (2) | National Public Health Programs (1) | Natural (1) |
| natural compounds (3) | Natural Polymers (1) | natural products (2) |
| NCC-PvPI; Hepatitis B vaccine; ADR/AE; VigiFlow; system organ class (SOC) (1) | Nebivolol (2) | nebivolol hydrochloride (1) |
| Necrosis. (1) | need assessment (1) | Nephroprotective (3) |
| Nephrotic syndrome (1) | Nephrotoxicity (1) | Nerium indicum (1) |
| neuropathy (1) | Neurosurgical (1) | neutropenia (1) |
| nevirapine (1) | new molecule (1) | Newborns (1) |
| Nicorandil (1) | Nicotine (1) | Nicotine dependence (1) |
| Nifedipine. (1) | Nigeria. (1) | nigrostriatal pathway (1) |
| Nil (8) | Nill (18) | niosome (1) |
| Niosomes (1) | Nitric acid (1) | Nitric oxide (3) |
| Nitrogen starvation (1) | NMDA (1) | NMDA receptors (1) |
| Nodular skin lesions (1) | Non-linear (1) | non-prescription medicine use (1) |
| Non-steroid anti-inflammatory (1) | Non-steroidal anti-inflammatory drugs (1) | Non-surgical endodontic therapy. (1) |
| nonamers. (1) | noncommunicable disease (1) | noncompliance (1) |
| Nonionic surfactants (1) | nootropic (1) | Norfloxacin (1) |
| Normoglycemic rats (1) | northeast India (1) | Nose to brain delivery (1) |
| Nothopanax scutellarium (1) | Nuclear medicine (1) | nuclear pharmacy (1) |
| Nucleo CMP (1) | Nude mice (1) | Nutmeg oil (1) |
| Nutraceuticals (1) | Nutrient starvation (1) | Nutrition (1) |
| Nystagmus Phenytoin toxicity (1) | O-Phenylene diamine (1) | Obesity (2) |
| Occupational health (1) | Ocimum gratissimum (1) | Off-label (1) |
| offending drugs (1) | Okra Mucilage (1) | Olmesartan (1) |
| olmesartan medoxomil (1) | Omega-6 fatty acid (1) | Omeprazole. (1) |
| Omics (1) | Oncology. (1) | ondansetron (3) |
| ondansetron hydrochloride (1) | OPD – Outpatient Department. (1) | open field (1) |
| Ophthalmic (1) | ophthalmic delivery (1) | ophthalmic inserts (1) |
| Opportunities (1) | Optimal stress (1) | optimization (7) |
| Oral bacteria (1) | Oral cancer (2) | oral disintegrating tablets (1) |
| Oral glucose tolerance (1) | oral glucose tolerance test (3) | Oral hypoglycemic drugs (1) |
| oral insulin (1) | Oral Rehabilitation (1) | Organ Toxicities (1) |
| organic acids (1) | organogel (1) | Organophosphate (1) |
| Origanum vulgare (1) | Original Article (3) | Originator. (1) |
| Orlistat (1) | orodispersible tablet (1) | orodispersible tablets (2) |
| Oscillopsia (1) | Osmotic pump (1) | Osteoarthritis (1) |
| Osteoblast (2) | Osteoclast (1) | OTC switch (1) |
| Otomycosis (2) | Outdoor patients (1) | Outpatients (1) |
| ovalbumin (1) | Ovarian (1) | Over-the-counter (1) |
| Overweight (1) | OVX (1) | oxazepinone (1) |
| oxcarbazepine (1) | Oxidation (1) | oxidative damage (1) |
| oxidative stress (6) | Oxyresveratrol (1) | oxytetracycline (1) |
| P-dimethylaminobenzaldeyde (1) | P-drug. (1) | P-drugs (1) |
| P-glycoprotein (1) | P. dulce (Fabaceae) (1) | p53 tumor suppressor gene (1) |
| Package insert (1) | Paediatric (2) | Pain (2) |
| Pain. (1) | Painkiller (1) | pair wise procedures (1) |
| Pakistan (2) | Pakistan. (4) | Paliperidone palmitate (1) |
| Pancreatitis. (1) | Pantoprazole (1) | papain (1) |
| Papain. (1) | PAR-2 receptor (1) | para-diaminobenzaldehyde (1) |
| paracetamol (2) | Paracetamol. (2) | Parkinson’s disease (1) |
| partial least square (1) | particle size analysis (1) | PASS (1) |
| passive avoidance learning (1) | Patch (1) | patents (2) |
| Pathological response (1) | Patient (2) | Patient adherence. (1) |
| patient counseling (1) | Patient counseling and Patient information leaflet (1) | patient education (1) |
| Patient health questionnaire (PHQ) (1) | Patient satisfaction (1) | Patient Survival (1) |
| patient-physician communication (1) | Patient-safety (1) | patients (2) |
| Patients. (1) | paw edema (1) | Paw edema. (1) |
| Paw volume (1) | PE 18:0/18:0-PEG 2000 (1) | Pectin (1) |
| pedagogy (1) | Pediatric (3) | Pediatric cancer (1) |
| Pediculosis (1) | Pegagan extract (1) | PEGylation (1) |
| Pemphigus vulgaris (1) | Penang (1) | penetration (3) |
| penetration enhancer (1) | penetration pressure (1) | penicillamine (1) |
| Penicillins (1) | pentylenetetrazole (1) | PEO (1) |
| Peperomia pellucida (L) Kunth (1) | Peperomia pellucida (L.) Kunth (3) | Peppas and Higuchi’s equations (1) |
| Peptic Ulcer. (1) | peptide vaccine (1) | Peptidoglycan (1) |
| percentage healing of wound area (1) | perception (3) | Periauricular tags. (1) |
| pericyclic fiber (1) | Periodontal disease (1) | periodontal diseases (1) |
| periodontal pocket (1) | Peripheral Neuropathy (1) | Permeation (2) |
| Peroxisome proliferator-activated receptorg (PPAR-γ) agonists (1) | Persistent ulcer (1) | Personal care products (2) |
| pH dependent approach (1) | pH independence (1) | pH-sensitive (1) |
| Phaleria marcocarpha (1) | Pharm. D. Integrated (1) | Pharm. D. Post Baccalaureate. (1) |
| pharma counseling (1) | pharmaceutical (1) | pharmaceutical advertisements (1) |
| Pharmaceutical care (2) | pharmaceutical care. (1) | pharmaceutical formulations (1) |
| Pharmaceutical Marketing (1) | Pharmaceutical Services (1) | Pharmaceutical-Care (1) |
| Pharmaceutical-industries (1) | Pharmacist (4) | Pharmacist intervention. (1) |
| pharmacist role in public health (1) | Pharmacists (1) | pharmacists India (1) |
| Pharmacodynamic (2) | Pharmacodynamic activity (1) | pharmacodynamics (2) |
| Pharmacogenetics (1) | Pharmacogenomics (1) | pharmacognostic standardization (1) |
| pharmacognostical (1) | pharmacognosy study (1) | Pharmacokinetic (4) |
| Pharmacokinetic interactions. (1) | pharmacokinetics (8) | Pharmacokinetics. (2) |
| Pharmacological properties (1) | Pharmacophore (3) | Pharmacovigilance (13) |
| Pharmacovigilance Programme of India (1) | Pharmacovigilance. (1) | Pharmacovigilante’s (1) |
| pharmacy (5) | pharmacy curriculum (2) | Pharmacy education (1) |
| Pharmacy Enforcement Division (1) | Pharmacy informatics (1) | Pharmacy services (1) |
| Phase diagrams (1) | Phase I studies (1) | Phase rule (1) |
| phase solubility (1) | phase solubility profile (1) | Phenobarbitone (1) |
| Phenolic (1) | phenolic compounds (2) | phenolics (1) |
| phenols (1) | Phenothiazine (1) | Phenytoin (2) |
| Phenytoin cold cream (1) | Phenytoin Toxicity (1) | Pheritima posthuma (1) |
| Phleboliths (1) | Phoenix dactylifera (1) | Phosphorylase kinase (1) |
| Photoprotection. (2) | Phthalates (1) | Phyllanthus emblica, (1) |
| Phylogenetic tree (1) | Physical fitness (1) | Physical stability (1) |
| Physichochemical Characterization (1) | Physicians (3) | physicochemical evaluation (1) |
| physicochemical properties (1) | physiochemical descriptor (1) | Physiological role (1) |
| Phytochemical (2) | phytochemical prospection (1) | Phytochemical screening (1) |
| Phytosome (1) | picrotoxin (1) | pictograms (1) |
| Pilgrims (1) | PIM (1) | Pinus merkusii (1) |
| pioglitazone (1) | piperazine citrate (1) | Piperine (1) |
| Piroxicam (1) | Pits and Fissures (1) | Pixel intensity. (1) |
| Plackett-Burman (1) | Plackett-Burman design (1) | plant extracts (1) |
| plasma (3) | Plasma concentration (1) | plasma concentrations (1) |
| Plasma creatinine (1) | Plasma insulin (1) | Plasma urea (1) |
| plasma-brain correlation (1) | Plasma. (1) | Plasmodium falciparum 3D7 (1) |
| Plasmodium falciparum. (1) | Platelet aggregation. (1) | Platelet rich fibrin membrane. (1) |
| Pleiotropic effects (1) | PLGA (1) | PLSR (1) |
| Pluronic F 127 (1) | Pneumonia (1) | Poison (2) |
| Poisoning pattern (1) | Polarography (1) | Poloxamer 188 (1) |
| Poloxamer 407 (2) | Poloxamer 407. (1) | poly (lactic-co-glycolic acid) (1) |
| Poly herbal (1) | poly(ε-caprolactone) (1) | polycaprolactone (1) |
| Polycystic Ovary Syndrome (1) | Polyelectrolyte complex (PEC) (1) | PolyElectrolytecomplex (1) |
| Polyethylene glycol (1) | Polyherbal (1) | polyherbal formulation (3) |
| Polymeric nanoparticles (2) | polypharmacy (6) | polypharmacy in diabetes mellitus. (1) |
| polyphenols (1) | Polysaccharide (1) | polyvinyl alcohol (2) |
| polyvinyl pyrrolidone (1) | Polyvinylpyrrolidone (1) | Polyvynil pyrrolidone (1) |
| Pomalidomide (1) | PON1 mRNA (1) | porosity (1) |
| Port-A Catheter. (1) | Positive and Negative stressors (1) | Positive coping strategies. (1) |
| Posology (1) | Possible mechanisms (1) | Posterior reversible encephalopathy syndrome (1) |
| Potassium (1) | Potassium Channel (1) | Potassium chloride (1) |
| Potassium Nitrate (1) | PPAR agonists (1) | PPARγ agonists. (1) |
| PPBG (1) | pPharmacokinetics (1) | PPP model (1) |
| practice (3) | practices (1) | pravastatin (1) |
| Pre ADMET (1) | pre prandial (1) | Pre University students (1) |
| Pre-authorization (1) | Prebiotic (2) | Precipitation (1) |
| precise (1) | Precision (1) | Predictors (1) |
| Pregabalin (1) | Pregnancy (2) | preliminary screening (1) |
| Premna esculenta (1) | prescriber (1) | Prescribing (1) |
| Prescribing errors (1) | Prescribing pattern. (1) | Prescription (3) |
| Prescription error. (1) | prescription monitoring (1) | prescription only medicines (1) |
| Prescription pattern (1) | Prescription review (1) | pressure dependent approach (1) |
| Prevalence (3) | Primary health care (2) | Primary Health Care. (1) |
| Principal component analysis (1) | principal component regression (1) | Pristane (1) |
| Private Medical College (1) | PRO (1) | Probable (1) |
| Probiotic (1) | Probiotics (1) | Problem-based learning (1) |
| process capability (1) | Process parameters. (1) | Products with Antimicrobial Action. (1) |
| progesterone (1) | Proniosomal gel (1) | propolis (1) |
| Proportional reporting ratio (1) | propranol hydrochloride (1) | Propranolol hydrochloride (1) |
| Prospective Study (2) | prostaglandins (1) | Proteasome activity (1) |
| protein proÞ le (1) | proteolytic enzymes (1) | Proton adduct (1) |
| Proton Pump Inhibitor (2) | Proton-pump Inhibitors (1) | Protransfersome (1) |
| Prteomics (1) | Pseudo ternary phase diagrams (1) | Pseudomonas aeruginosa (1) |
| Psidium Guajava (1) | Psychological mindedness (1) | Psychomotor (1) |
| Psychosis (2) | Psychotropic drugs (1) | Psychotropics (1) |
| Pterocarpus indicus (1) | Pterocarpus indicus Willd (1) | Public health hospital (1) |
| Public hospital (1) | Publication (1) | Publications (2) |
| Pulmonary Fibrosis (1) | pulmonary hypertension (1) | Pulmonary toxicity (1) |
| Punica granatum (1) | pyrazine (1) | pyrazoline (1) |
| pyrazolines (1) | Pyrimidine (1) | Q1F (1) |
| QOL (1) | QSAR (2) | qualitative (1) |
| Qualitative analysis (1) | qualitative study (1) | Quality (1) |
| quality assurance (1) | Quality Control (1) | Quality Indicators (1) |
| quality of internet information (1) | quality of life (4) | quantitative structure-activity relationship (1) |
| Quercetin (2) | quinazolin-4(3H)one (1) | quinazolinone (1) |
| Quinazolinone. (1) | quinoline derivatives (1) | R2 values (1) |
| Rabbits. (1) | radical scavenger (1) | radicals (1) |
| radiopharmaceuticals (1) | radiopharmacy (1) | Radioprotective (1) |
| Raillietina echinobothrida (1) | raloxifene hydrochloride (1) | Raman spectroscopy (2) |
| ramipril (2) | ranitidine (1) | Ranitidine hydrochloride (2) |
| Ranitidine’. (1) | ranolazine (1) | Ransmission electron microscopy (1) |
| Rapid disintegration (1) | Rasagiline mesylate (1) | Rat (1) |
| ratio test procedures (1) | Rational pharmacotherapy. (1) | Rational prescribing (1) |
| Rational use of medicine (1) | rational use of medicines (1) | rats (1) |
| Rattus novergicus (1) | re-precipitation (1) | recognized standards (1) |
| recovery studies (1) | Red ginger (1) | Reflective pedagogy paradigm (1) |
| reforms (1) | Regeneration (1) | Regression analysis (1) |
| Regressions statistics (1) | Regulation (1) | Regulations (1) |
| regulatory (2) | Regulatory affairs (1) | regulatory system (1) |
| Relative performance (1) | release kinetics (3) | Release studies. (1) |
| relese kinetics (1) | Removable denture (1) | Renoprotection (1) |
| Renoprotective (1) | repaglinide (2) | reperfusion (1) |
| research (1) | Research Skills. (1) | reserpine (1) |
| Resident doctors (1) | Resistance (3) | Resistant starch (1) |
| Respiratory tract (1) | Response Surface Methodology (1) | Response surface methodology. (1) |
| Response to antiretroviral therapy (1) | Resveratrol (2) | retail pharmacy (1) |
| Retention. (1) | Retinopathy (1) | retrospective cohort (1) |
| Retrospective study (1) | reversed-phase chromatography (1) | Rhabdomyolysis (1) |
| Rhaphidophora pinnata (1) | rhizomes (1) | Riboflavin (1) |
| Rice Bran Oil (1) | Rifampicin (1) | Ringer’s dextrose (1) |
| Ringer’s lactate. (1) | Riociguat (1) | Risk factor. (1) |
| Risk factors (1) | Risk Factors. (1) | Rituximab (1) |
| rivastigmine (1) | RNAi (1) | RNAi technology (1) |
| RNTCP (1) | Rodenticides (1) | root (1) |
| Root canal infection (1) | Roots extract (1) | Ropinirole (1) |
| rosuvastatin (2) | rosuvastatin calcium (1) | Royal Malaysian Custom Officer (1) |
| RP-HPLC (6) | RP-HPLC method (1) | RP-TLC/Densitometry (1) |
| RT-qPCR (1) | Rubus fraxinifolius (1) | Rubus rosifolius (1) |
| rupatadine (1) | rutin (1) | ß avonoids (2) |
| S. mutans (1) | S.salivarius (1) | S.sanguis (1) |
| Saccharin (1) | Safe handling guidelines (1) | Safety (1) |
| Sage (1) | Saponin (1) | saponins (1) |
| Sappan wood (1) | Saraschandra (1) | Saudi Arabia (1) |
| Saussurea lappa (1) | scanning electron microscopy (3) | Scientific Advertisements (1) |
| Scientometrics (3) | sclerotherapy (1) | Scores. (1) |
| Se- DeM ODT Expert system (1) | Second-line agents (1) | Secondary Level (1) |
| seizure outcome (1) | Seizures (1) | Selected area electron diffraction (1) |
| Self medication (1) | self-emulsifying drug delivery system (1) | Self-Harm (1) |
| self-medication (5) | self-nanoemulsification (1) | Semi-permanent hair dye (1) |
| senna spectabilis (1) | Sensitive (1) | sensory cortical activity. (1) |
| separation (1) | sepbox (1) | Septic shock (1) |
| Sequences distillation (1) | Sequential optimization (1) | Serum (1) |
| Serum Glutamate-Pyruvate Transaminase (1) | Serum Glutamic Oxaloacetic Transaminase (1) | Serum triglyceride (1) |
| Serum. (1) | sesame oil (1) | severe febrile neutropenia (1) |
| Severe sepsis (1) | Severity (1) | Sexual dysfunction in diabetes (1) |
| Shodhana (1) | Short Communication (3) | short-term memory (1) |
| Sida rhomboidea.Roxb (1) | Side effect (1) | signal detection (1) |
| Signal detection. (1) | silymarin (1) | similarity factor (f2) (2) |
| simplex lattice (1) | Simplex Lattice Design (2) | simultaneous determination (2) |
| simultaneous extraction (1) | simvastatin (1) | simvastatin. (1) |
| Single nucleotide polymorphism (1) | sintering (1) | siRNA (1) |
| siRNA. (2) | SIRT1 (1) | Sirtuin (1) |
| six sigma (1) | SJS (1) | SLS (1) |
| Smix. (1) | Smoking (1) | smoking cessation. (1) |
| Smoking. (1) | smooth muscle cells (1) | Snake bite (1) |
| SNEDDS (2) | sobatum (1) | Social Media (1) |
| Social sexual. (1) | SOD (1) | Sodium (1) |
| sodium alginate (1) | sodium alginate. (2) | sodium carboxy methyl cellulose (1) |
| sodium starch glycolate (3) | Sodium starch glycolate (SSG) (1) | Solanum nigrum (1) |
| Solanum trilobatum (1) | Solanum viarum (1) | Solanum xanthocarpum, (1) |
| Solasodine (1) | solid dispersion (5) | solid lipid nanoparticles (1) |
| Solid lipid nanoparticles. (1) | solubility (5) | Solubility enhancement (1) |
| Solubility. (1) | solvent casting (1) | solvent evaporation (3) |
| Solvent evaporation. (1) | sonication time (1) | sonophoresis (1) |
| Sorafenib (1) | Spacedrepetition. (1) | spasmolytic (1) |
| speciÞ city (1) | Spectrometric (1) | spectrophotometry (2) |
| sperm count (2) | SPF (1) | Spiro compounds (1) |
| Spleen colony assay (1) | sponge implantation assay (1) | sponsors (1) |
| Spontaneous-Reporting. (1) | Sprague Dawley (1) | spray drying (1) |
| SPSS 20. (1) | ST segment elevation (1) | stability (1) |
| stability indicating (1) | stability indicating and validation. (1) | Stability indicating assay (1) |
| Stability indicating assay method (1) | stability indicating method of artemether (1) | stability indicating. (1) |
| Stability of the physical properties (1) | Stability test (1) | stability. (1) |
| stain removal (1) | stakeholders (1) | Standardization (4) |
| Staphylococcus aureus (1) | Starlac (1) | Statin pathway (1) |
| Statins. (1) | Statistical Modeling (1) | Statistical optimization (1) |
| Stelechocarpus burahol (1) | Stem bark extract (1) | Stephania hernandifolia (1) |
| Stereospermum suaveolens (1) | Stereospermum tetragonum (2) | Sterilization Procedures (1) |
| Steroidal alkaloid (1) | Steudnera colocasiifolia (1) | Stevens-Johnson syndrome (1) |
| Stilbene (1) | Stimulantia (1) | Stimuli (1) |
| Stomatitis under prosthesis (1) | Streptococci (1) | Streptococcus mutans (2) |
| Streptokinase (1) | Streptomonospora arabica (1) | Streptomyces (1) |
| Streptozotocin (2) | Streptozotocin (STZ) (1) | streptozotocin-induced diabetes (1) |
| Streptozotocin. (1) | stress (3) | stress studies (2) |
| stroke and cardiac pacemaker. (1) | Stroke prevention (1) | structural descriptor (1) |
| Structured Communication. (1) | Stryphnodendron rotundifolium (1) | students (3) |
| students’ residence (1) | Sub Clinical Hypothyroidism. (1) | Sub-acute Inflammation (1) |
| Subcutaneous fat (1) | sublingual films (1) | substituted acetophenones (1) |
| sucrase (1) | Sudan (1) | Sulfonylurea (2) |
| Sulfonylureas (1) | Sulphorhodamine-B (1) | Sun (1) |
| sun protection factor (2) | Sunlight (1) | Sunscreens. (1) |
| Super disintegrants (1) | superdisintegrants (2) | Superdisintergrants (1) |
| Superoxide Dismutase. (1) | superoxidedismutase (1) | superporous hydrogel composite (1) |
| Supply Chain Management (1) | support staff. (1) | Surface properties (1) |
| surfactant (1) | surfactants (1) | surgical prophylaxis. (1) |
| Surgical. (1) | Survey questionnaire (1) | survey. (1) |
| Survival rate (1) | sustained release (3) | sustained release pellets (1) |
| sustained release. (1) | Sweet orange peel extract (Citrus sinensis) (1) | swelling index (1) |
| swelling studies (1) | Symptoms (1) | Synchronous spectrofluorimetry. (1) |
| Synergism. (1) | Synthesis (2) | Synthesis; 1-allyl-3-benzoylthiourea; COX-2; Analgesic; Lead Compound; (1) |
| Systematic Review. (1) | Systemic steroids. (1) | Systems biotechnology (1) |
| Systolic dysfunction. (1) | T cell epitope (1) | T regs (1) |
| Tab. Pardopa (1) | Tablet Compression (1) | Tacrolimus (1) |
| Tacrolimus Once Daily (1) | Tacrolimus Twice Daily. (1) | Tactile stimulation (1) |
| tail suspension test (1) | Tamarindus indica (1) | Tamilians (1) |
| Tamoxifen (1) | Target delivery (1) | Targeted drug delivery system (1) |
| taste masking (2) | tasteless complex (1) | taxane (1) |
| Taxus baccata (1) | Teaching Hospital (1) | Technology (1) |
| technology-enhanced learning (1) | tegument (1) | telmisartan (1) |
| TEN (1) | Tenofovir disoproxil fumarate (1) | Tephrosia purpurea ethanolic seed extract (TpEt). (1) |
| Terminalia bellirica (1) | Termineliachebula;Plants; Galls;Albendazole; anthelmintic; Drug. (1) | Ternary phase diagram (1) |
| terpenoids (1) | Tertiary Care (1) | Tertiary care hospital (2) |
| testicular damage (1) | testosterone (3) | Tetrapreniltoluquinone (1) |
| thalassemia major (1) | therapeutic angiogenesis (1) | therapeutic dose (1) |
| therapeutic drug monitoring (2) | therapeutic effectiveness (1) | Thermoreversible gel (1) |
| Thixogel (1) | THP-1 (2) | Three component system (1) |
| thrombocytopenia (1) | Thrombolysed subjects (1) | Thrombolytic (1) |
| thrombolytic enzymes (1) | Thyme oleoresin (1) | Thyrotoxicosis. (1) |
| time dependent approach (1) | Time lag (1) | Timed release (1) |
| Tobacco (2) | Tobacco smoking (1) | tolbutamide (1) |
| Tolerance (1) | Tooth brush. (1) | Toothpaste. (1) |
| Topical delivery. (1) | Topical. (1) | Total flavonoid (1) |
| Total flavonoid content (2) | Total phenolic (2) | Total phenolic content (1) |
| total polyphenolic content (1) | total quality management (1) | toxicity (4) |
| Toxicity. (3) | traditional medicine (2) | Training of Central sterile and supply department employees (1) |
| tramadol HCL (1) | Tramadol Hydrochloride (1) | Trans-cinnamic acid (1) |
| Trans-resveratrol (1) | Transcriptomics. (1) | transdermal (2) |
| transfer latency (1) | Transfersome (2) | Transfersomes. (1) |
| Translation (1) | Transmucosal (1) | Transmucosal patch (1) |
| Trauma induced external inflammatory root resorption (1) | Treatment adherence. (1) | Treatment outcomes (1) |
| Triacylglycerol. (1) | Triamcinalone Acetonide (TRIA) (1) | Trichoderma reesei. (1) |
| Tricyclic antidepressants (TCA) (1) | Triglycerides (1) | Trigonella foenum graecum (1) |
| Trigonelline (1) | Trinidad & Tobago (1) | trinitrobenzene sulfonic acid (1) |
| Triphala (1) | triple distilled water (1) | Triterpenoid. (1) |
| Triterpenoids (1) | Triticum aestivum. (1) | Tropaeolum majus L (1) |
| tropicamide (1) | Troponin-I (1) | Trypsin (1) |
| TSLP (1) | Tuberculosis (3) | Tuberculosis/HIV (1) |
| Tumor response (1) | Tween 80. (1) | Twisted (1) |
| Tylophora indica (1) | Tylophorinidine. (1) | type 2 diabetes (2) |
| Type 2 diabetes mellitus. (1) | type 2 diabetes. (1) | UACR (1) |
| UCPMP Guidelines (1) | ultrasonication-solvent evaporation technique (1) | Unani medicine (1) |
| Uncemented (1) | Underutilization of insulin. (1) | Unethical practices. (1) |
| Unique device identification (1) | Universities (1) | Unlicensed. (1) |
| Unnecessary use. (1) | UPLC/ESI-Q-TOF-MS/MS method Validation (1) | Urban area (1) |
| urea (1) | Urinary Hydrogen Peroxide (1) | Urinary tract infection (UTI) (1) |
| Urine Albumin to Creatinine Ratio (1) | Urine volume (1) | urolithiasis (1) |
| Urtica dioica L (1) | Usefulness. (1) | Uterine fibroid (1) |
| Uterine Perforation. (1) | UV derivative spectrophotometry (1) | UV detection (2) |
| UV Spectrophotometric method (1) | UV spectrophotometry (1) | UV-spectrophotometric method (1) |
| UV-spectrophotometry (2) | Vaccine (1) | Vaccine design (1) |
| vada (1) | vaginal gel (1) | Vaginitis. (1) |
| Vakrasana (1) | validation (16) | Valium (1) |
| Valproate (1) | valsartan (1) | Vanillin (1) |
| Vanillosmopsis arborea. (1) | vascular bundle (1) | vascular permeability (2) |
| vascular progenitors (1) | VED analysis (2) | VED analysis. (2) |
| VEGFR-2 (1) | Venetoclax (1) | Venography and Hemangioma (1) |
| Venous malformations (VMs) (1) | verapamil (3) | Verapamil HCl (1) |
| Viability (1) | Vincristine. (1) | Vinegar (1) |
| Virtual Screening (1) | Viscosity (1) | visible Spectrophotometry (1) |
| visible spectroscopy (1) | Visual analogue scale. (1) | Vitamin D (2) |
| Vitamin D deficiency (1) | Vitamin D. (1) | vitamin E (1) |
| vitamin E d-α-tocopheryl polyethylene glyco1000 succinate (1) | Vitamin. (1) | Vitex agnus Castus (1) |
| Voltage–gated calcium channels (1) | warfarin (2) | Warning signs (1) |
| Water hyacinth (2) | web-based learning (1) | Weibull parameters (1) |
| West timor (1) | Western blot technique (1) | Wet gangrene (1) |
| wet granulation (1) | wetting time (1) | Wheat (1) |
| White/red patch (1) | WHO-QOL BREF questionnaire (1) | WHO-UMC causality assessment system. (1) |
| Wilson disease (1) | Wistar rats. (1) | Withania somnifera. (1) |
| Withdrawal (1) | Women. (1) | Work protection (1) |
| Wound Healing (1) | Wrightia tinctoria (1) | writhing (1) |
| X-ray diffraction (1) | X-ray imaging study. (1) | X-ray powder diffraction (1) |
| xanthan gum (1) | Xanthangum (1) | XDR-TB (1) |
| Xenografts (1) | Xenografts. (1) | XRD (1) |
| Ylang-ylang (1) | Yoga (1) | Yucca gloriosa L. (1) |
| Zea m1 pollen allergen (1) | Zero order release (1) | zero order spectrophotometry (1) |
| zeta potential (1) | zidovudine (1) | Zika virus (1) |
| zinc (1) | Zinc ion (1) | Zingiber officinale (1) |
| Zingiberaceae (1) | zopiclone (1) | [BMIM]PF6 (1) |
| Þ rst-order derivative spectroscopy (1) | Α-amylase (2) | α-glucosidase (1) |
| α-mangostin (1) | β Amyloid1-42 (1) | β-carboline (1) |
| β-carotene production (1) | β-cyclodextrin (2) | γ-oryzanol (1) |
| ε-amino groups (1) | | |
